A trial looking at MK-3475A for non small cell lung cancer (MK3475A-F84)
This trial is comparing a new drug called MK-3475A with pembrolizumab for non small cell lung cancer (NSCLC).
This trial is comparing a new drug called MK-3475A with pembrolizumab for non small cell lung cancer (NSCLC).
This trial is looking at adding VP-002 to nab-paclitaxel and gemcitabine chemotherapy.
This trial is looking at whether a personalised ketogenic diet therapy can improve the outcome of standard treatment for lung cancer.
This study is looking at exercise and diet to help reduce muscle loss in people with advanced bowel cancer.
This trial is comparing standard treatment with a new drug called BAY 2927088 as a first treatment for non small lung cell lung cancer.
This trial is looking at a drug called BNT327 in combination with standard chemotherapy.
This trial is looking at adding a drug called celecoxib to standard treatment to improve treatment for advanced cancer.
This trial is comparing BNT327 and standard chemotherapy with atezolizumab and standard chemotherapy.
This trial is looking at pressurised intraperitoneal aerosolised chemotherapy (PIPAC) for cancer that has spread to the peritoneum or primary peritoneal cancer
This trial is looking at adding certain treatments to hormone treatment for prostate cancer that has spread to other parts of the body.